Bovine CCL8 (MCP-2) ELISA

Catalog Number:
DIY2035B
Application:
ELISA
100% Homology:
Bos indicus (zebu), Bos mutus (wild yak), Bos taurus (cattle)

Components

UsageQuantityComponentSize
Detection Antibody50 µgKPB2034B-050
Standard5 µgRP1903B-005
Capture Antibody100 µgKP2033B-1001 Pack (<= 10 Plates)
Capture Antibody100 µg X 2KP2033B-1001 Pack (<= 20 Plates)
  • The Bovine CCL8 (C-C motif chemokine ligand 8, also known as MCP-2) ELISA is designed for the quantitative measurement of CCL8 in bovine (cattle) cell culture supernatants and can also be used to measure CCL8 in additional biological sample types reported in the literature, including serum, plasma, milk, bronchoalveolar lavage (BAL) fluid, and tissue lysates, with minor protocol modifications recommended to optimize performance across different matrices. The bovine CCL8 protein sequence is identical to that of Bos indicus (zebu) and Bos mutus (wild yak), enabling this assay to be used for accurate detection across these closely related species. CCL8 is a pro-inflammatory CC chemokine produced by monocytes, macrophages, endothelial cells, fibroblasts, and epithelial cells in response to inflammatory cytokines and microbial stimuli, and it functions through chemokine receptors such as CCR1, CCR2, CCR3, and CCR5 to recruit monocytes, T lymphocytes, NK cells, and other immune effector cells to sites of infection or tissue injury. In healthy cattle and related species, circulating CCL8 levels are typically low or near the limit of detection (often <10-20 pg/mL in serum or plasma), but concentrations can increase during mastitis, respiratory disease, enteric infections, systemic inflammation, or experimental immune stimulation, depending on disease severity and timing of sampling. Measurement of bovine CCL8 provides valuable insight into leukocyte recruitment, innate immune activation, inflammatory disease progression, and host-pathogen interactions in veterinary and translational research settings. The ELISA kit contains a capture antibody, detection antibody, and recombinant bovine CCL8 protein standard validated for use together in an ELISA format; kit components are not supplied in matched quantities and may be purchased separately. This product is for research use only, not for use in diagnostic or therapeutic procedures, and is manufactured in the USA.
Storage Conditions2°C to 8°C or -20°C
Country Of OriginUSA
Bovine CCL8 (C–C motif chemokine ligand 8, also known as MCP-2 – Monocyte Chemoattractant Protein-2) is a proinflammatory chemokine that regulates leukocyte recruitment and inflammatory responses in cattle (Bos taurus). CCL8 belongs to the CC chemokine family, which includes related chemokines such as CCL2 (MCP-1), CCL7 (MCP-3), and CCL13 (MCP-4) that coordinate monocyte and leukocyte trafficking during immune activation. In cattle, CCL8 is produced by macrophages, fibroblasts, endothelial cells, epithelial cells, and other immune cells in response to infection, inflammatory cytokines, or tissue injury. CCL8 exerts its biological effects through interaction with chemokine receptors including CCR1, CCR2, CCR3, and CCR5, promoting chemotaxis and activation of monocytes, macrophages, dendritic cells, T lymphocytes, and eosinophils at sites of infection or inflammation. In bovine health, CCL8 contributes to immune responses against bacterial and viral pathogens, including those involved in mastitis, bovine respiratory disease complex, and other inflammatory conditions, where recruitment of immune cells is essential for pathogen clearance. Because chemokine-mediated leukocyte trafficking is critical for effective host defense, bovine CCL8 is studied in veterinary immunology, infectious disease research, and host–pathogen interaction studies, helping to improve understanding of immune regulation and disease resistance in cattle.
  • Chemokine

Please choose a size to see price


Reagents for Animal Model and Animal Health Research

Kingfisher Biotech, Inc.
1000 Westgate Drive
Suite 123
Saint Paul, MN 55114

Phone: 651-646-0089
Fax: 651-646-0095

Animal Antibodies

Newsletter

"